Applied Therapeutics, Inc. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 3 rows, 3 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-05-26: Reporting owner Silberstein Charles; Form 3; Security No securities beneficiallly owned; Transaction Holding.
- 2020-03-05: Reporting owner Hansard Adam; Form 3; Security No securities beneficially owned; Transaction Holding.
- 2019-05-29: Reporting owner Shendelman Shoshana; Form 3/A; Security Series A Perferred Stock; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-05-26 holding as of filing | Silberstein Charles Officer (Chief Financial Officer) | 3 | No securities beneficiallly owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2020-05-26 | |
| 2020-03-05 holding as of filing | Hansard Adam Officer (Chief Commercial Officer) | 3 | No securities beneficially owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2020-03-05 | |
| 2019-05-29 holding as of filing | Shendelman Shoshana Director, Officer (President and CEO), 10% Owner | 3/A | Series A Perferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2019-05-29 |